BioSpace News Archive

Press Releases

Noveris Health Sciences Announces Proposed Private Placement of Convertible Debentures for up to $500,000

August 21, 2026
·
4 min read
Policy

Lawmakers urge FDA to enact new China policies after 3 gene therapy trial deaths

Three fatalities occurring recently in Chinese clinical trials have spurred two members of U.S. Congress to urge the FDA to enact new policies designed to protect American patients.

August 21, 2026
·
4 min read
·
Gabrielle Masson
Deals

Werewolf and Ambros to tie the knot in $150M rare disease deal

The merger, which would create a new company bearing Ambros’ name, will help support development of Ambros’ non-opioid painkiller for patients with debilitating limb injuries.

August 21, 2026
·
2 min read
·
Michael Gibney
Press Releases

MustGrow Receives First Milestone Payment from Bayer AG

• Bayer AG has paid MustGrow the first development milestone payment. • The MustGrow / Bayer AG License and Collaboration Agreement, signed in December 2023, covers soil applications of MustGrow’s mustard-based biocontrol technologies in Europe, Middle East and Africa.

August 21, 2026
·
6 min read
Duchenne muscular dystrophy

Capricor investor calls for change as company awaits decision on Duchenne candidate

Kaos Capital in a letter to other Capricor Therapeutics shareholders called for “an immediate meeting, board change, and capital-preservation plan.” The biotech recently put all other pipeline work on pause as it awaits an Aug. 22 PDUFA date for embattled cell therapy deramiocel.

August 21, 2026
·
3 min read
·
Heather McKenzie
Press Releases

2026 Clinical and Operational Review Benchmarks Top Hair Restoration Facilities in Turkey for International Patients

New industry evaluation examines surgical protocols, physician oversight, and aftercare standards across leading medical tourism centers in Istanbul.

August 21, 2026
·
3 min read